Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Gastroenterology ; 138(5): 1810-22, 2010 May.
Article in English | MEDLINE | ID: mdl-20138038

ABSTRACT

BACKGROUND & AIMS: The molecular mechanism underlying epithelial metaplasia in Barrett's esophagus remains unknown. Recognizing that Hedgehog signaling is required for early esophageal development, we sought to determine if the Hedgehog pathway is reactivated in Barrett's esophagus, and if genes downstream of the pathway could promote columnar differentiation of esophageal epithelium. METHODS: Immunohistochemistry, immunofluorescence, and quantitative real-time polymerase chain reaction were used to analyze clinical specimens, human esophageal cell lines, and mouse esophagi. Human esophageal squamous epithelial (HET-1A) and adenocarcinoma (OE33) cells were subjected to acid treatment and used in transfection experiments. Swiss Webster mice were used in a surgical model of bile reflux injury. An in vivo transplant culture system was created using esophageal epithelium from Sonic hedgehog transgenic mice. RESULTS: Marked up-regulation of Hedgehog ligand expression, which can be induced by acid or bile exposure, occurs frequently in Barrett's epithelium and is associated with stromal expression of the Hedgehog target genes PTCH1 and BMP4. BMP4 signaling induces expression of SOX9, an intestinal crypt transcription factor, which is highly expressed in Barrett's epithelium. We further show that expression of Deleted in Malignant Brain Tumors 1, the human homologue of the columnar cell factor Hensin, occurs in Barrett's epithelium and is induced by SOX9. Finally, transgenic expression of Sonic hedgehog in mouse esophageal epithelium induces expression of stromal Bmp4, epithelial Sox9, and columnar cytokeratins. CONCLUSIONS: Epithelial Hedgehog ligand expression may contribute to the initiation of Barrett's esophagus through induction of stromal BMP4, which triggers reprogramming of esophageal epithelium in favor of a columnar phenotype.


Subject(s)
Barrett Esophagus/metabolism , Cell Communication , Epithelial Cells/metabolism , Esophageal Neoplasms/metabolism , Esophagus/metabolism , Hedgehog Proteins/metabolism , Mesoderm/metabolism , Precancerous Conditions/metabolism , Signal Transduction , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Animals , Barrett Esophagus/etiology , Barrett Esophagus/pathology , Bile/metabolism , Bile Reflux/complications , Bile Reflux/metabolism , Bone Morphogenetic Protein 4/metabolism , Calcium-Binding Proteins , Cell Communication/genetics , Cell Differentiation , Cell Line , DNA-Binding Proteins , Disease Models, Animal , Epithelial Cells/pathology , Esophageal Neoplasms/pathology , Esophagus/pathology , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/metabolism , Hedgehog Proteins/genetics , Humans , Hydrogen-Ion Concentration , Keratins/metabolism , Mesoderm/pathology , Metaplasia , Mice , Mice, Transgenic , Patched Receptors , Patched-1 Receptor , Phenotype , Precancerous Conditions/etiology , Precancerous Conditions/pathology , RNA Interference , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , SOX9 Transcription Factor/metabolism , Signal Transduction/genetics , Transfection , Tumor Suppressor Proteins
2.
Genes Dev ; 22(6): 770-85, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-18347096

ABSTRACT

Medulloblastoma is an embryonal tumor thought to arise from the granule cell precursors (GCPs) of the cerebellum. PATCHED (PTCH), an inhibitor of Hedgehog signaling, is the best-characterized tumor suppressor in medulloblastoma. However, <20% of medulloblastomas have mutations in PTCH. In the search for other tumor suppressors, interest has focused on the deletion events at the 17p13.3 locus, the most common genetic defect in medulloblastoma. This chromosomal region contains HYPERMETHYLATED IN CANCER 1 (HIC1), a transcriptional repressor that is a frequent target of epigenetic gene silencing in medulloblastoma. Here we use a mouse model of Ptch1 heterozygosity to reveal a critical tumor suppressor function for Hic1 in medulloblastoma. When compared with Ptch1 heterozygous mutants, compound Ptch1/Hic1 heterozygotes display a fourfold increased incidence of medulloblastoma. We show that Hic1 is a direct transcriptional repressor of Atonal Homolog 1 (Atoh1), a proneural transcription factor essential for cerebellar development, and show that ATOH1 expression is required for human medulloblastoma cell growth in vitro. Given that Atoh1 is also a putative target of Hh signaling, we conclude that the Hic1 and Ptch1 tumor suppressors cooperate to silence Atoh1 expression during a critical phase in GCP differentiation in which malignant transformation may lead to medulloblastoma.


Subject(s)
Cerebellar Neoplasms/etiology , Kruppel-Like Transcription Factors/physiology , Medulloblastoma/etiology , Receptors, Cell Surface/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cerebellar Neoplasms/pathology , Cerebellum/cytology , Cerebellum/metabolism , Chromatin Immunoprecipitation , Female , Fibroblasts/cytology , Fibroblasts/metabolism , Fluorescent Antibody Technique , Gene Expression Profiling , Gene Silencing , Genes, Tumor Suppressor , Humans , Immunoenzyme Techniques , Male , Medulloblastoma/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Oligonucleotide Array Sequence Analysis , Patched Receptors , Patched-1 Receptor , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sirtuin 1 , Sirtuins , Transfection
3.
Proc Natl Acad Sci U S A ; 104(10): 4048-53, 2007 Mar 06.
Article in English | MEDLINE | ID: mdl-17360475

ABSTRACT

The cancer stem cell hypothesis suggests that malignant growth depends on a subset of tumor cells with stem cell-like properties of self-renewal. Because hedgehog (Hh) signaling regulates progenitor cell fate in normal development and homeostasis, aberrant pathway activation might be involved in the maintenance of such a population in cancer. Indeed, mutational activation of the Hh pathway is associated with medulloblastoma and basal cell carcinoma; pathway activity is also critical for growth of other tumors lacking such mutations, although the mechanism of pathway activation is poorly understood. Here we study the role and mechanism of Hh pathway activation in multiple myeloma (MM), a malignancy with a well defined stem cell compartment. In this model, rare malignant progenitors capable of clonal expansion resemble B cells, whereas the much larger tumor cell population manifests a differentiated plasma cell phenotype that pathologically defines the disease. We show that the subset of MM cells that manifests Hh pathway activity is markedly concentrated within the tumor stem cell compartment. The Hh ligand promotes expansion of MM stem cells without differentiation, whereas the Hh pathway blockade, while having little or no effect on malignant plasma cell growth, markedly inhibits clonal expansion accompanied by terminal differentiation of purified MM stem cells. These data reveal that Hh pathway activation is heterogeneous across the spectrum of MM tumor stem cells and their more differentiated progeny. The potential existence of similar relationships in other adult cancers may have important biologic and clinical implications for the study of aberrant Hh signaling.


Subject(s)
Hedgehog Proteins/physiology , Multiple Myeloma/pathology , Signal Transduction , Stem Cells/metabolism , Animals , Cell Line, Tumor , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Neoplasm Transplantation , Phenotype , Plasma Cells/metabolism , Syndecan-1/biosynthesis , Veratrum Alkaloids/pharmacology
4.
Biochemistry ; 45(7): 2006-13, 2006 Feb 21.
Article in English | MEDLINE | ID: mdl-16475789

ABSTRACT

The oligomeric state of BAFF (B cell activing factor), a tumor necrosis factor (TNF) family cytokine that plays a critical role in B cell development and survival, has been the subject of recent debate. Myc-tagged BAFF starting at residue Gln136 was previously reported to crystallize as trimers at pH 4.5, whereas a histidine-tagged construct of BAFF, starting at residue Ala134, formed a virus-like cluster containing 60 monomers when crystallized at pH 9.0. The formation of the BAFF 60-mer was pH dependent, requiring pH >or= 7.0. More recently, 60-mer formation was suggested to be artificially induced by the histidine tag, and it was proposed that BAFF, like all other TNF family members, is trimeric. We report here that a construct of BAFF with no amino-terminal tag (Ala134-BAFF) can form a 60-mer in solution. Using size exclusion chromatography and static light scattering to monitor trimer to 60-mer ratios in BAFF preparations, we find that 60-mer formation is pH-dependent and requires histidine 218 within the DE loop of BAFF. Biacore measurements established that the affinity of Ala134-BAFF for the BAFF receptor BAFFR/BR3 is similar to that of myc-Gln136-BAFF, which is exclusively trimeric in solution. However, Ala134-BAFF is more efficacious than myc-Gln136-BAFF in inducing B cell proliferation in vitro. We additionally show that BAFF that is processed and secreted by 293T cells transfected with full-length BAFF, or by a histiocytic lymphoma cell line (U937) that expresses BAFF endogenously, forms a pH-dependent 60-mer in solution. Our results indicate that the formation of the 60-mer in solution by the BAFF extracellular domain is an intrinsic property of the protein, and therefore that this more active form of BAFF may be physiologically relevant.


Subject(s)
Membrane Proteins/physiology , Protein Structure, Quaternary , Tumor Necrosis Factor-alpha/physiology , Animals , B-Cell Activating Factor , Chromatography, Gel , Humans , Hydrogen-Ion Concentration , Light , Mice , Molecular Weight , Pichia/metabolism , Scattering, Radiation
5.
Curr Biol ; 14(12): 1094-8, 2004 Jun 22.
Article in English | MEDLINE | ID: mdl-15203003

ABSTRACT

The extension of the plasma membrane during cell crawling or spreading is known to require actin polymerization; however, the question of how pushing forces derive from actin polymerization remains open. A leading theory (herein referred to as elastic propulsion) illustrates how elastic stresses in networks growing on curved surfaces can result in forces that push particles. To date all examples of reconstituted motility have used curved surfaces, raising the possibility that such squeezing forces are essential for actin-based pushing. By contrast, other theories, such as molecular ratchets, neither require nor consider surface curvature to explain pushing forces. Here, we critically test the requirement of substrate curvature by reconstituting actin-based motility on polystyrene disks. We find that disks move through extracts in a manner that indicates pushing forces on their flat surfaces and that disks typically move faster than the spheres they are manufactured from. For a subset of actin tails that form on the perimeter of disks, we find no correlation between local surface curvature and tail position. Collectively the data indicate that curvature-dependent mechanisms are not required for actin-based pushing.


Subject(s)
Actins/metabolism , Bacterial Proteins/metabolism , Biopolymers/metabolism , Membrane Proteins/metabolism , Movement/physiology , Actins/physiology , Bacterial Proteins/isolation & purification , Biomechanical Phenomena , Biopolymers/physiology , Cells, Cultured , Membrane Proteins/isolation & purification , Microscopy, Electron, Scanning , Microspheres , Polystyrenes
SELECTION OF CITATIONS
SEARCH DETAIL
...